Sterile Water description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Sterile Water

Baxter Healthcare Corporation

Sterile Water for Injection, USP in VIAFLEX Plastic Container For Drug Diluent Use Only


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

STERILE WATER DESCRIPTION

Sterile Water for Injection, USP, is sterile, nonpyrogenic, distilled water in a single dose container for intravenous administration after addition of a suitable solute. It may also be used as a dispensing container for diluent use. No antimicrobial or other substance has been added. The pH is 5.5 (5.0 to 7.0). The osmolarity is 0.

The VIAFLEX plastic container is fabricated from a specially formulated polyvinyl chloride (PL 146 Plastic). The amount of water that can permeate from inside the container into the overwrap is insufficient to affect the solution significantly. Solutions in contact with the plastic container may leach out certain chemical components from the plastic in very small amounts; however, biological testing was supportive of the safety of the plastic container materials.

CLINICAL PHARMACOLOGY

Sterile Water for Injection, USP is used for fluid replacement only after suitable additives are introduced to approximate isotonicity and to serve as a vehicle for suitable medications.

STERILE WATER INDICATIONS AND USAGE

Sterile Water for Injection, USP is indicated in the aseptic preparation of parenteral solutions.

STERILE WATER CONTRAINDICATIONS

Sterile Water for Injection, USP is a hemolytic agent due to its hypotonicity. Therefore, it is contraindicated for intravenous administration without additives.

WARNINGS

Do not use for intravenous injection unless adjusted to approximate isotonicity with a suitable solute.

PRECAUTIONS

Do not administer unless solution is clear and seal is intact.

STERILE WATER ADVERSE REACTIONS

The administration of a suitable admixture of prescribed additives may be associated with adverse reactions because of the solution or the technique of administration including febrile response, infection at the site of injection, venous thrombosis or phlebitis extending from the site of injection, extravasation, and hypervolemia.

If an adverse reaction does occur, discontinue the infusion, evaluate the patient, institute appropriate therapeutic countermeasures, and save the remainder of the fluid for examination if deemed necessary.

STERILE WATER DOSAGE AND ADMINISTRATION

Following suitable admixture of prescribed additives, the dosage is usually dependent upon the age, weight and clinical condition of the patient as well as laboratory determinations. See directions accompanying additive drug.

Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration whenever solution and container permit.

Injections in VIAFLEX plastic containers are intended for intravenous administration using sterile equipment.

Additives may be incompatible. Complete information is not available. Those additives known to be incompatible should not be used. Consult with pharmacist, if available. If, in the informed judgment of the physician, it is deemed advisable to introduce additives, use aseptic technique. Do not store an unused portion of Sterile Water for Injection, USP. Mix thoroughly when additives have been introduced. Do not store solutions containing additives.

HOW SUPPLIED

Sterile Water for Injection, USP is supplied in VIAFLEX plastic containers as follows:

1000 mL 2B0304 NDC 0338-0013-04

Exposure of pharmaceutical products to heat should be minimized. Avoid excessive heat. It is recommended the product be stored at room temperature (25°C); brief exposure up to 40°C does not adversely affect the product.

DIRECTIONS FOR USE OF VIAFLEX PLASTIC CONTAINER

Warning: Do not use plastic containers in series connections. Such use could result in air embolism due to residual air being drawn from the primary container before administration of the fluid from the secondary container is completed.

To Open

Tear overwrap down side at slit and remove solution container. Some opacity of the plastic due to moisture absorption during the sterilization process may be observed. This is normal and does not affect the solution quality or safety. The opacity will diminish gradually. Check for minute leaks by squeezing inner bag firmly. If leaks are found, discard solution as sterility may be impaired. See following directions.

Preparation for Administration After Rendering Isotonic

1. Suspend container from eyelet support.

2. Remove plastic protector from outlet port at bottom of container.

3. Attach administration set. Refer to complete directions accompanying set.

Warning: Additives may be incompatible.

To add medication before administration

1. Prepare medication site.

2. Using syringe with 19 to 22 gauge needle, puncture resealable medication port and inject.

3. Mix solution and medication thoroughly. For high density medication such as potassium chloride, squeeze ports while ports are upright and mix thoroughly.

To add medication during administration

1. Close clamp on the set.

2. Prepare medication site.

3. Using syringe with 19 to 22 gauge needle, puncture resealable medication port and inject.

4. Remove container from IV pole and/or turn to an upright position.

5. Evacuate both ports by squeezing them while container is in the upright position.

6. Mix solution and medication thoroughly.

7. Return container to in use position and continue administration.

Baxter Healthcare Corporation

Deerfield, IL 60015 USA

7-19-31-347 Rev. September 2002

BAXTER, VIAFLEX, and PL 146 are trademarks of Baxter International Inc.

PACKAGE LABEL.PRINCIPLE DISPLAY PANEL

Sterile Water
Sterile Water Container Label LOT EXP2B0304NDC 0338-0013-04STERILE WATERSTERILE WATER FOR INJECTION USPFOR DRUG DILUENT USE ONLY1000mLNO ANTIMICROBIAL OR OTHER SUBSTANCE HAS BEEN ADDEDpH 5.5 (5.0 TO 7.0) STERILE NONPYROGENIC SINGLEDOSE CONTAINER ADMINISTER INTRAVENOUSLY ONLY AFTERRENDERING APPROXIMATELY ISOTONIC WITH SUITABLE SOLUTEADDITIVES MAY BE INCOMPATIBLE CONSULT WITH PHARMACISTIF AVAILABLE WHEN INTRODUCING ADDITIVES USE ASEPTICTECHNIQUE MIX THOROUGHLY DO NO STORE DOSAGE INTRAVENOUSLY AS DIRECTED BY A PHYSICIAN SEEDIRECTIONS CAUTIONS SQUEEZE AND INSPECT INNER BAGWHICH MAINTAINS PRODUCT STERILITY DISCARD IF LEAKS ARE FOUND MUST NOT BE USED IN SERIES CONNECTIONS DO NOTUSE UNLESS SOLUTION IS CLEAR RX ONLY STORE UNIT IN MOISTURE BARRIER OVERWRAP AT ROOM TEMPERATURE (25°C)UNTIL READY TO USE AVOID EXCESSIVE HEAT SEE INSERTVIAFLEX PLUS CONTAINER PL 146 PLASTICBAXTER VIAFLEX AND PL 146 ARE TRADEMARKS OF BAXTER INTERNATIONAL INCFOR PRODUCT INFORMATION 1-800-933-0303BAXTERBAXTER HEALTHCARE CORPORATIONDEERFIELD IL 60015 USAMADE IN THE USA Sterile Water Carton Label

2B0304X 14-1000 ML UNITS

VIAFLEX® CONTAINER

STERILE WATER FOR INJ., USP

EXP

XXXXX

SECONDARY BAR CODE

(17) XXXXX (10) XXXXX

LOT

XXXXX

PRIMARY BAR CODE

(01) 50303380013048

NOTE: Lot and Exp. Date added at time of printing.

Secondary bar code human readable is variable and will be

added at time of printing. The parenthesis are not

encoded in actual bar code.

Sterile Water

Water INJECTION, SOLUTION

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:0338-0013
Route of Administration INTRAVENOUS DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
water 100 mL

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:0338-0013-04 1000 in 1 BAG

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA018632 1982-06-30


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.